Jack Ball

Jack T.
Ball is currently Director at Carterra, Inc., SwitchGear Genomics, Inc., RealBio Technology, Inc., ViroCyt, Inc. (since 2013), KromaTid, Inc., and President at Tyball Associates, Inc. Former positions include Chief Executive Officer at Amnis Corp., Chief Executive Officer & Director at Solulink, Inc. (2013–2019), Executive Chairman at Aquaro Histology, Inc., Director at Celsee LLC, Essen Instruments, Inc., 3D Biomatrix, Inc., Swift Biosciences, Inc. (2010–2021), PHASIQ, Inc., NanoCellect Biomedical, Inc. (2021–2023), Independent Director at Cytek Biosciences, Inc. (2025–2026), Senior VP & General Manager-Life Sciences Group at Orchid Cellmark, Inc., President-North America Sales at Amersham Pharmacia Biotech, Inc. (2012–2013), Chief Commercial Officer at Accuri Cytometers, Inc. (2006–2011), Chief Commercial Officer at Molecular Probes, Inc., and Principal at GE Healthcare Bio-Sciences, Inc. Education includes undergraduate studies at the University of Georgia.